Your session is about to expire
← Back to Search
Unknown
DZD9008 and carbamazepine for Healthy Subjects
Phase 1
Waitlist Available
Research Sponsored by Dizal Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 10 days after study drug administration
Awards & highlights
Study Summary
This trial is testing how two drugs interact with each other when given to healthy adults.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 10 days after study drug administration
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 10 days after study drug administration
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Area under the concentration-time curve from time 0 to infinity (AUC0-inf) when dosed alone or coadministered with carbamazepine (Part B)
Area under the concentration-time curve from time 0 to infinity (AUC0-inf) when dosed alone or coadministered with itraconazole (Part A)
Area under the concentration-time curve from time 0 to time of last quantifiable concentration (AUC0-t) when dosed alone or coadministered with carbamazepine (Part B)
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: DZD9008 and itraconazoleExperimental Treatment1 Intervention
Subjects in arm 1 will receive DZD9008 single dose on Day 1, and the second dose of DZD9008 along with itraconazole after the wash-out period.
Group II: DZD9008 and carbamazepineExperimental Treatment1 Intervention
Subjects in arm 2 will receive DZD9008 single dose on Day 1, and the second dose of DZD9008 along with carbamazepine after the wash-out period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Itraconazole
FDA approved
Carbamazepine
FDA approved
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Dizal PharmaceuticalsLead Sponsor
20 Previous Clinical Trials
2,009 Total Patients Enrolled
Tianwei ZhangStudy DirectorDizal Pharma
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger